Grace Mann

Grace Mann is the Executive Director at EpiBiologics, a position they have held since 2025. They previously served as the Senior Director of Clinical Oncology and Neurology at Corcept Therapeutics from 2020 to 2025 and held multiple roles in clinical science and project management at various pharmaceutical companies, including Onyx Pharmaceuticals and Puma Biotechnology, from 2011 to 2019. Grace began their career as a Medicinal Chemist at Exelixis and has also contributed to academia as a Visiting Lecturer and researcher at The University of Hong Kong. They earned a Ph.D. in Chemistry from Yale University and a B.S. in Chemistry from the University of California, Berkeley.